ArticleFrontiers in oncology2024

Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment.

Tangyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.